Curie Capital

About Curie Capital

Curie Capital is an Amsterdam-based venture capital firm focused on early-stage life sciences companies, specifically targeting Seed and Series A investments in biotechnology, pharmaceutical, and medical technology. We apply a disciplined scientific and commercial diligence process to identify the highest-potential ventures developing first- or best-in-class therapeutics, diagnostics, and class IIb/III medical devices. We seek out true scientific innovations in accessible markets, led by experienced and visionary management teams. Curie Capital brings significantly more to the table than just capital; we take a highly active, hands-on role in helping founders build robust companies from the ground up. Through our targeted funds, strong risk appetite, and deep sector expertise, we support groundbreaking medical products and guide portfolio companies to critical value-inflection points. For therapeutics, this means funding development to the clinical proof-of-concept stage, while for diagnostics and medtech, we aim to accelerate the path to global sales. We actively contribute to the value creation of our investments by leveraging our extensive network to build strong syndicates with experienced co-investors, recruit top-tier leadership, and secure world-class advisors. By systematically de-risking each proposition both scientifically and operationally, we position our portfolio companies for later-stage institutional investment, successful commercialization, and ultimately, significant value realization and optimized exits for our investors.